Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-27

Clinical Trial Update: NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 trial updating the effect of adding NSAIDs to anti-TNF therapy versus anti-TNF therapy alone on progression of structural damage in Ankylosing Spondylit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-TNF therapy
  • NSAIDs (non-steroidal anti-inflammatory drugs)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED